Fundraising Fox

Biotech Investors & VC Firms in Switzerland

92 firms in this list, with a median first check of $540K. 23 of them lead rounds. Generated from verified public data and updated continuously.

Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
50 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
41 people
Metaplanet
TallinnSeed–Late Stage$500K – $10M
4 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
Kickfund
ZurichPre-Seed–Seed$950K
5 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
M Ventures
Los AngelesSeed–Growth$10.8M
9 people
SHS Capital
TübingenGrowth–Late Stage$10M – $50M
42 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
18 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
21 people
HealthCap
StockholmSeed–Growth
30 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
14 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
25 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
28 people
Hardware Club
New YorkPre-Seed–Series A
6 people
Apollo Health Ventures
BerlinSeed–Series A
32 people
Blue Horizon Corporation
ZurichPre-Seed–Late Stage
2 people
+ND Capital
WoodsideSeed–Late Stage$540K – $5.4M
18 people
VI Partners
AltendorfSeed–Series B$2.2M – $4.5M
15 people
MIG Capital AG
MunichSeed–Growth$1.1M – $10.8M
23 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Creathor Ventures
Bad HomburgSeed–Late Stage$540K – $10.8M
3 people
XGEN Venture
MilanPre-Seed–Series A
21 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.